Skip to main content

Table 1 Ceramides after elastase injection

From: Ceramides: a potential therapeutic target in pulmonary emphysema

Ceramide

Day 0

Day 1

Day 2

Day 3

Day 4

Day 5

Day 8

Day 14

Day 21

Ceramide 16:0

45.63 ± 33.52

32.04 ± 14.16

110.54 ± 57.84 *

48.52 ± 3.87

21.91 ± 6.73

52.84 ± 1.86

40.97 ± 21.74

46.66 ± 27.52

38.04 ± 20.54

Ceramide 18:0

2.47 ± 0.68

3.55 ± 1.71

5.50 ± 1.55*

2.97 ± 0.48

1.38 ± 0.23

1.86 ± 0.61

2.20 ± 1.18

2.11 ± 0.72

2.46 ± 1.58

Ceramide 20:0

1.39 ± 0.40

1.92 ± 0.77

4.25 ± 1.98*

1.86 ± 0.36

0.79 ± 0.16

1.14 ± 0.40

1.41 ± 0.79

1.30 ± 0.41

1.32 ± 0.83

Ceramide 22:0

9.60 ± 2.47

14.12 ± 7.82

29.75 ± 11.28*

16.31 ± 2.80

6.66 ± 2.30

9.00 ± 2.85

10.89 ± 5.74

10.13 ± 2.12

10.40 ± 5.40

Ceramide 24:0

34.83 ± 12.23

34.97 ± 20.00

112.76 ± 47.82*

44.75 ± 6.09

19.09 ± 6.43

36.70 ± 16.82

40.97 ± 20.87

37.58 ± 9.04

41.64 ± 19.19

Ceramide 24:1

24.89 ± 8.47

52.02 ± 37.77

95.90 ± 41.08*

60.25 ± 9.65*

23.04 ± 9.75

33.03 ± 12.09

32.90 ± 20.18

30.01 ± 8.14

31.41 ± 16.8

Dihydro Ceramide 18:0

0.53 ± 0.24

2.01 ± 0.40*

1.49 ± 0.53

1.51 ± 0.44

0.75 ± 0.34

0.36 ± 0.10

0.48 ± 0.31

0.40 ± 0.16

0.33 ± 0.15

Dihydro Ceramide 24:0

2.17 ± 0.68

4.64 ± 1.14

10.74 ± 4.32*

3.77 ± 1.95

1.72 ± 0.34

1.83 ± 0.85

2.21 ± 0.99

1.85 ± 0.49

1.83 ± 0.85

  1. BAL fluid from 12 mice per group was collected and processed using LC-MS/MS. Data are expressed as Mean + SEM ng/ml BAL fluid. *p<0.05, when compared to control animals at the same time-point.